Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Finger

Showing results (321-330 of 342) with videos related to

Pageof 35
Sort By:
Translational Vision Science & Technology|July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study ReportBethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 24, 2017
[Ophthalmological health care of the institutionalized elderly : The OVIS study]P P Fang, A Schnetzer, D G Kupitz, et al.
The British Journal of Ophthalmology|June 8, 2026
Subretinal drusenoid deposits (reticular pseudodrusen) in the general population: a European multicohort studyMatthias M Mauschitz, Frank G Holz, Alexander K Schuster, et al.
Trials|July 20, 2020
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTARJan H Terheyden, Frank G Holz, Steffen Schmitz-Valckenberg, et al.
Ophthalmology Science|February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical PracticeRobyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
BMC Medical Research Methodology|March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR studyJan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Eye (London, England)|February 5, 2025
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR studyJan Henrik Terheyden, Hannah M P Dunbar, Steffen Schmitz-Valckenberg, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 3, 2025
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study ReportJan Henrik Terheyden, Frank G Holz, Charlotte Behning, et al.
BMC Medical Research Methodology|June 17, 2026
Recruiting children and young people with vision impairment for clinical research - experience from the SeeMyLife studyLisa Gittel, Robert P Finger, Verena Richter, et al.
Pageof 35

Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
Translational Vision Science & Technology|July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study ReportBethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 24, 2017
[Ophthalmological health care of the institutionalized elderly : The OVIS study]P P Fang, A Schnetzer, D G Kupitz, et al.
The British Journal of Ophthalmology|June 8, 2026
Subretinal drusenoid deposits (reticular pseudodrusen) in the general population: a European multicohort studyMatthias M Mauschitz, Frank G Holz, Alexander K Schuster, et al.
Trials|July 20, 2020
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTARJan H Terheyden, Frank G Holz, Steffen Schmitz-Valckenberg, et al.
Ophthalmology Science|February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical PracticeRobyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
BMC Medical Research Methodology|March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR studyJan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Eye (London, England)|February 5, 2025
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR studyJan Henrik Terheyden, Hannah M P Dunbar, Steffen Schmitz-Valckenberg, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 3, 2025
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study ReportJan Henrik Terheyden, Frank G Holz, Charlotte Behning, et al.
BMC Medical Research Methodology|June 17, 2026
Recruiting children and young people with vision impairment for clinical research - experience from the SeeMyLife studyLisa Gittel, Robert P Finger, Verena Richter, et al.
Pageof 35